Tyra Biosciences, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 21.07 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.45B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
Details
| Name | Tyra Biosciences, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 87 |
| Founded | 2018 |
| Ipo Date | 2021-09-15 |
| Ceo | Todd Harris |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US90240B1061 |
| Cusip | 90240B106 |
| Cik | 1863127 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Todd Harris Ph.D. | Co-Founder, Chief Executive Officer, President and Director |
| Bhavesh Ashar M.B.A. | Chief Operating Officer |
| Dr. Douglas Warner M.D. | Chief Medical Officer |
| Daniel Bensen | Co-Founder and Chief Discovery Officer |
| Alan Fuhrman CPA | Chief Financial Officer |
| Julia Rueb | Vice President of Finance and Principal Accounting Officer |
| Dr. Robert L. Hudkins Ph.D. | Chief Technology Officer |
| Dr. Ronald V. Swanson Ph.D. | Chief Scientific Officer |
| Ali D. Fawaz J.D. | General Counsel and Secretary |
| Sarah Honig | Senior Vice President of Corporate Development and Strategy |
Contact
| Address | 2656 State Street, Carlsbad, California 92008, United States |
| Phone | 619 728 4760 |
| Website | https://tyra.bio |